Literature DB >> 659543

Determination of retinoic acid (13-cis- and all-trans-) and aromatic retinoic acid analogs possessing anti-tumor activity, in biological fluids by high-performance liquid chromatography.

C V Puglisi, J A De Silva.   

Abstract

A sensitive and specific high-performance liquid chromatographic assay was developed for the determination of 13-cis- and all-trans-retinoic acid in blood or urine with an overall recovery of 90 +/- 5.0% and a limit of detection of 10-20 ng/ml of sample. The method provides for rapid and simple quantitation of the compounds using 1 ml of blood. The assay was applied in the determination of blood levels of 13-cis-retinoic acid in the dog following intravenous and oral administration of 9.5 mg/kg and 2.0 mg/kg doses, and in man following a single 100-mg oral dose and following divided daily doses totalling 2 mg per kg of body weight. The assay is also applicable with minor modifications to the determination of a series of aromatic retinoic acid analogs of clinical interest as anti-tumor agents.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659543     DOI: 10.1016/s0021-9673(00)85078-5

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

Review 2.  Clinical pharmacokinetics of the retinoids.

Authors:  R W Lucek; W A Colburn
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

3.  Pharmacokinetics of all-trans retinoic acid in pediatric patients with leukemia.

Authors:  K Takitani; H Tamai; T Morinobu; N Kawamura; M Miyake; T Fujimoto; M Mino
Journal:  Jpn J Cancer Res       Date:  1995-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.